Skip to content

To study the effect of vidang taila Nasya and Goghrut Nasya in Migraine

RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF VIDANG TAILA NASYA AND GOGHRITA NASYA IN THE MANAGEMENT OF ARDHAVBHEDAK

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019755
Enrollment
72
Registered
2019-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura

Interventions

Intervention1: VIDANG TAILA: Nasya nasal drops 2 Drops in each nostril for 7 days Control Intervention1: GOGHRITA: Nasya nasal drops 2 Drops in each nostril for 7 days

Sponsors

Pallavi Pandurang Vyavahare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from symptoms of Ardhavbhedak i.e. Ardha Manya, Bhru, Shankha, Karna, Akshi, Lalat Ativedanam and Shastra Arni Nibha and Bhrama Patient between age group 20 to 60 yrs. Patient of either gender.

Exclusion criteria

Exclusion criteria: Patients suffering from sinusitis systemic disorders like hypertension and dibetes Secondary headache caused by meningitis tumor encephalitis and refractive errors Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Subjective criteria ( by using Grades and Visual analogues Pain Scale) Bhrama (giddiness) Shatra Arni Nibha (Throbbing pain) Unilateral severe pain affecting neck brow ear and orbital area forehead region Objective criteria (by Gradation) 1 severity of headache 2 frequency of headache 3 duration of headache 4 Episode of Vomiting 4 Duration of AuraTimepoint: 21 days

Secondary

MeasureTime frame
Study the concept of Ardhavbhedak and Migraine in details Study the Nasya Kriyakalpa and its uses indications contra indications complicationsTimepoint: 21 days

Countries

India

Contacts

Public ContactDr Pallavi Pandurang Vyavahare

Sumatibhai Shah Ayurved and Hospital

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026